Advancing Care for Rheumatic Immune-Related Adverse Events
CanRIO is a nationwide network of rheumatologists and researchers dedicated to improving outcomes for patients experiencing immune-related side effects from cancer immunotherapy.
Latest News & Publications
Stay current with CanRIO's research and achievements
Chronicity of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis
Read more →Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis
Read more →Find a Specialist Near You
CanRIO investigators across Canada have expertise in managing rheumatic immune-related adverse events from cancer immunotherapy. Our clinic finder helps connect patients and referring physicians with specialists in their area.
For Patients: Bring this information to your oncologist or family doctor to request a referral.
For Physicians: Contact clinics directly for consultations on challenging cases.
Interactive Clinic Map
Accredited Education for Healthcare Professionals
Earn CME credits while learning about the diagnosis and management of rheumatic immune-related adverse events from immune checkpoint inhibitors.
Learning Modules
Self-paced video modules covering inflammatory arthritis, myositis, vasculitis, sarcoidosis, and management of pre-existing autoimmune disease.
- 5 comprehensive modules
- CME certificate on completion
- Free for healthcare providers
CanRIO Learning Rounds
Live collaborative sessions hosted in partnership with universities across Canada. Discuss challenging cases and learn from leading experts.
- 3-4 sessions per year
- Virtual attendance via Zoom
- For healthcare practitioners
Trusted by Clinicians Across Canada
CanRIO brings together rheumatologists, oncologists, and researchers from academic centres nationwide to advance the care of patients with immune-related adverse events.
15+
Participating Centres
47
Publications
500+
Cohort Patients
2017
Established
Support Our Research
Your donation to the Arthritis Research Committee (ARC) helps fund CanRIO's research and educational initiatives, advancing care for patients with rheumatic immune-related adverse events.
Donate to Support CanRIO
